Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of "what you need to know" podcast episodes from data presented at CROI 2026.

Launch/Release Date: February 24, 2026

Activity Expiration Date: January 31, 2027

FACULTY

David Wohl, MD

Professor-Institute of Global Health and Infectious Diseases, The University of North Carolina at Chapel Hill

Site Leader-UNC Global HIV Clinical Research Unit at Chapel Hill

Co-Director-UNC Special Pathogen Response Center (SPAR)

Co-Director-UNC Project-Liberia

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of "what you need to know" podcast episodes from data presented at CROI 2026.

Launch/Release Date: February 24, 2026

Activity Expiration Date: January 31, 2027

FACULTY

David Wohl, MD

Professor-Institute of Global Health and Infectious Diseases, The University of North Carolina at Chapel Hill

Site Leader-UNC Global HIV Clinical Research Unit at Chapel Hill

Co-Director-UNC Special Pathogen Response Center (SPAR)

Co-Director-UNC Project-Liberia

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

One of the most active areas in HIV research is ART switch strategies in virologically suppressed patients with HIV (PWH). Recent switch studies highlight the use of INSTI-, non-INSTI, and long-acting ART regimens as well as a shifting in strategies–from one of only achieving viral suppression towards also addressing simplification, minimizing long-term toxicities, managing comorbidities, and improving quality of life. This activity is designed to update healthcare professionals with the latest cutting-edge evidence on ART switch strategies in virologically suppressed PWH that were reported in 2025 as well as discuss their implications on patient management trends for 2026.

Launch/Release Date: November 24, 2025

Activity Expiration Date: October 31, 2026

FACULTY

Paul Sax, MD

Clinical Director

Division of Infectious Diseases

Brigham and Women’s Hospital

Professor of Medicine

Harvard Medical School

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.